Where's My Data? Evaluating Visualizations with Missing Data
Sign Up to like & getrecommendations! Published in 2019 at "IEEE Transactions on Visualization and Computer Graphics"
DOI: 10.1109/tvcg.2018.2864914
Abstract: Many real-world datasets are incomplete due to factors such as data collection failures or misalignments between fused datasets. Visualizations of incomplete datasets should allow analysts to draw conclusions from their data while effectively reasoning about… read more here.
Keywords: visualizations missing; missing data; data evaluating; evaluating visualizations ... See more keywords
Are In Vitro Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.01072-18
Abstract: The purpose of this review is to critically analyze published data evaluating the impact of azole pharmacokinetic and pharmacodynamic parameters, MICs, and Candida species on clinical outcomes in patients with candidemia. Clinical breakpoints (CBPs) for… read more here.
Keywords: data evaluating; susceptibility; treatment; treatment candidemia ... See more keywords
Reliability of administrative data for evaluating the quality of systemic treatment for cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.8_suppl.208
Abstract: 208Background: There is ongoing interest in leveraging administrative data to examine quality but methodological concerns persist. We evaluated the reliability of a previously established panel of ... read more here.
Keywords: data evaluating; reliability administrative; evaluating quality; quality systemic ... See more keywords
Real-world data evaluating immunotherapy markers and checkpoint inhibitor response among GI cancers in a large community-based oncology network.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.3_suppl.113
Abstract: 113Background: Checkpoint inhibitor (CPI) therapies have shown prolonged survival in patients (pts) with microsatellite instability (MSI). Tumor mutation burden (TMB) has also been associated with ... read more here.
Keywords: checkpoint inhibitor; evaluating immunotherapy; data evaluating; oncology ... See more keywords